NVS
Novartis AG ADR
NYSE: NVS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$147.85
+3.44% today
Updated 2026-04-30
Market cap
$280.79B
P/E ratio
20.32
P/S ratio
4.96x
EPS (TTM)
$7.16
Dividend yield
3.26%
52W range
$102 – $165
Volume
2.1M
Novartis AG ADR (NVS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8.71B | $9.21B | $9.77B | $12.19B | $14.07B | $14.31B | $14.19B | $13.17B | $13.90B | $11.90B | $11.47B | $12.62B | $14.27B | $13.63B | $13.65B | $15.07B | $14.24B | $14.46B | $17.62B | $19.24B |
| Capital expenditures | $2.32B | $3.13B | $2.32B | $2.73B | $2.23B | $2.39B | $3.31B | $3.77B | $3.70B | $3.85B | $2.88B | $2.75B | $3.35B | $2.26B | $2.58B | $2.97B | $2.67B | $2.75B | $3.81B | $1.56B |
| Depreciation | $1.99B | $2.86B | $2.67B | $2.30B | $3.42B | $5.79B | $4.95B | $4.99B | $4.75B | $5.58B | $6.04B | $6.08B | $6.89B | $5.83B | $6.46B | $6.11B | $7.18B | $8.28B | $6.07B | $5.35B |
| Stock-based comp | $522.00M | $570.00M | $567.00M | $642.00M | $655.00M | $790.00M | $746.00M | $730.00M | $744.00M | $773.00M | $671.00M | $683.00M | $759.00M | $758.00M | $738.00M | $736.00M | $823.00M | $865.00M | $1.04B | $1.10B |
| Free cash flow | $6.39B | $6.08B | $7.45B | $9.46B | $11.84B | $11.92B | $10.89B | $9.40B | $10.19B | $8.05B | $8.60B | $9.88B | $10.92B | $11.37B | $11.06B | $12.10B | $11.56B | $11.71B | $13.80B | $17.69B |
| Investing cash flow | $-6.58B | $-6.24B | $-10.37B | $-14.22B | $-15.76B | $-792.00M | $-5.67B | $-3.35B | $881.00M | $-10.78B | $-3.44B | $-3.12B | $-5.59B | $-2.23B | $-13.18B | $4.21B | $1.47B | $5.60B | $-7.51B | $-4.90B |
| Financing cash flow | $-4.97B | $-9.32B | $-2.57B | $2.81B | $4.12B | $-15.02B | $-6.67B | $-8.77B | $-8.15B | $-9.18B | $-5.31B | $-7.73B | $-4.24B | $-13.63B | $-2.21B | $-16.26B | $-20.56B | $-14.28B | $-11.74B | $-14.94B |
| Dividends paid | $2.05B | $2.60B | $3.35B | $3.94B | $4.49B | $5.37B | $6.03B | $6.10B | $6.81B | $6.64B | $6.47B | $6.50B | $6.97B | $6.64B | $6.99B | $7.37B | $7.51B | $7.25B | $7.62B | $7.86B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |